Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6149 USD | -9.31% |
|
-3.55% | -42.02% |
10/06 | BioSig Technologies Appoints Ferdinand Groenewald as Interim CFO | MT |
15/05 | Alaunos Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
-42.02% | 98.46L | |
+20.17% | 13TCr | |
+24.67% | 12TCr | |
+23.55% | 2.79TCr | |
-17.74% | 2.1TCr | |
-16.13% | 1.69TCr | |
-15.21% | 1.62TCr | |
+11.91% | 1.48TCr | |
-47.10% | 1.48TCr | |
+54.50% | 1.41TCr |
- Stock Market
- Equities
- TCRT Stock
- News Alaunos Therapeutics, Inc.
- Transcript : ZIOPHARM Oncology, Inc. Presents at 38th Annual J.P Morgan Healthcare Conference, Jan-13-2020 through Jan-16-2020